Drug Information

Drug General Information
Drug ID
D06ZWL
Former ID
DNC000194
Drug Name
Amdoxovir
Drug Type
Small molecular drug
Indication HBV infection [ICD9: 070.2-070.3; ICD10:B16, B18.0, B18.1] Phase 2 [524146]
Structure
Download
2D MOL

3D MOL
Formula
C9H12N6O3
Canonical SMILES
C1C(OC(O1)CO)N2C=NC3=C2N=C(N=C3N)N
InChI
1S/C9H12N6O3/c10-7-6-8(14-9(11)13-7)15(3-12-6)4-2-17-5(1-16)18-4/h3-5,16H,1-2H2,(H4,10,11,13,14)/t4-,5-/m1/s1
InChIKey
RLAHNGKRJJEIJL-RFZPGFLSSA-N
CAS Number
CAS 145514-04-1
PubChem Compound ID
124088
PubChem Substance ID
601090, 10240976, 12015169, 14749890, 17397047, 29304217, 50064444, 57340752, 80251935, 103630415, 104420037, 126663316, 127346821, 129144604, 134223829, 134339696, 134339828, 135078037, 137129355, 137264472, 140029030, 179149945, 184527249, 198959851, 223659539, 223765036, 226508232, 241036419
SuperDrug ATC ID
J05AB04
SuperDrug CAS ID
cas=036791045
Target and Pathway
Target(s) HIV reverse transcriptase Target Info Modulator
References
Ref 524146ClinicalTrials.gov (NCT01738555) A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.